Aimei Health Technology Issues $34,330 Promissory Note to Extend Business Combination Deadline

Reuters12-09
<a href="https://laohu8.com/S/AFJK">Aimei Health</a> Technology Issues $34,330 Promissory Note to Extend Business Combination Deadline

Aimei Health Technology Co. Ltd. has extended the period to consummate its initial business combination by one month, from December 6, 2025 to January 6, 2026, by depositing $34,330.96 into its trust account for public shareholders. To fund this extension, the company issued an unsecured promissory note totaling $34,330.96, equally divided between Aimei Health Ltd. and United Hydrogen Group Inc. The note, issued on December 5, 2025, bears no interest and is payable upon the completion of the business combination with United Hydrogen. The lenders have the option to convert the note into private units of Aimei Health Technology Co. Ltd. at a price of $10.00 per unit prior to the deal's closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-026631), on December 08, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment